Axid patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6930119 BRAINTREE Liquid pharmaceutical composition
Jul, 2022

(1 year, 9 months ago)

Axid is owned by Braintree.

Axid contains Nizatidine.

Axid has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Axid are:

  • US6930119

Axid was authorised for market use on 25 May, 2004.

Axid is available in solution;oral dosage forms.

The generics of Axid are possible to be released after 17 July, 2022.

Drugs and Companies using NIZATIDINE ingredient

Market Authorisation Date: 25 May, 2004

Treatment: NA


How can I launch a generic of AXID before it's drug patent expiration?
More Information on Dosage

AXID family patents

Family Patents